Karyopharm Therapeutics KPTI
NASDAQ KPTI
$0.80 -0.07 (-8.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Karyopharm Therapeutics (KPTI) Selling, General & Administrative (2012 - 2026)

Updated

Karyopharm Therapeutics (KPTI) posted Selling, General & Administrative of $25.92 million for Q2 2026, down 9.0% from $28.48 million a year earlier.

Analysis

Karyopharm Therapeutics (KPTI) Selling, General & Administrative (2012 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Karyopharm Therapeutics was $103.77 million, down 6.2% year-over-year; for FY2025, it was $105.21 million, down 8.9% from FY2024.

  • Annual Selling, General & Administrative has declined for three consecutive years, with a five-year compound annual growth rate of -3.6% (FY2020 to FY2025).
  • In prior years, Karyopharm Therapeutics' Selling, General & Administrative was $115.44 million in FY2024 (-12.5%), $131.88 million in FY2023 (-9.3%), $145.4 million in FY2022 (+1.1%) and $143.85 million in FY2021 (+13.8%).
  • Quarterly Selling, General & Administrative has run from a low of $22.77 million in Q4 2025 to a high of $38.77 million in Q1 2022 over five years.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2021, with growth of 13.4%; the weakest was Q1 2024, with a decline of 17.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Karyopharm Therapeutics 23.15 Mn -203.27 Mn 32.35 Mn 25.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.92 Mn
Dec 31, 2025 22.77 Mn
Sep 30, 2025 26.61 Mn
Jun 30, 2025 28.48 Mn
Mar 31, 2025 27.35 Mn
Dec 31, 2024 27.19 Mn
Sep 30, 2024 27.63 Mn
Jun 30, 2024 31.07 Mn
Mar 31, 2024 29.55 Mn
Dec 31, 2023 30.69 Mn
Sep 30, 2023 30.81 Mn
Jun 30, 2023 34.48 Mn
Mar 31, 2023 35.91 Mn
Dec 31, 2022 34.65 Mn
Sep 30, 2022 34.65 Mn
Jun 30, 2022 37.34 Mn
Mar 31, 2022 38.77 Mn
Dec 31, 2021 34.56 Mn
Sep 30, 2021 35.10 Mn
Jun 30, 2021 36.53 Mn
API Access

Karyopharm Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KPTI&period=max&api_key=YOUR_API_KEY